Related Experiment Videos
[Drug dependence--diagnostic and therapeutic aspects]
1Psychiatrische Universitätsklinik, Basel.
Therapeutische Umschau. Revue Therapeutique
|July 1, 1997
Summary
Drug dependence in Switzerland is driven by patient-doctor relationships and strict regulations, often involving sedatives like benzodiazepines. Understanding patient motivations and clinical syndromes is key to prevention and treatment strategies.
Area of Science:
- Pharmacology
- Psychiatry
- Public Health
Context:
- Strict regulatory environment in Switzerland influencing drug dependence.
- Patient-doctor relationship as a primary factor in drug dependence.
- Prevalence of benzodiazepines, sedatives, stimulants, and opioids in dependence cases.
Purpose:
- To analyze the factors contributing to drug dependence in Switzerland.
- To describe patient characteristics and motivations for drug use.
- To outline clinical syndromes and therapeutic strategies for drug dependence.
Summary:
- Drug dependence in Switzerland is significantly shaped by the patient-doctor dynamic within a regulated framework.
- Commonly involved substances include benzodiazepines, sedatives, stimulants (weight-control products), and opioids.
- Patient motivations range from seeking psychotropic effects to habituation from long-term treatment or non-specific overconsumption.
Impact:
- Informs clinical practice regarding patient-doctor communication and prescription patterns.
- Guides the development of targeted therapeutic and preventive strategies for drug dependence.
- Highlights the need for tailored interventions considering diverse patient motivations and substance types.